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Sir, 18 
 19 
The worldwide dissemination of bacteria producing New Delhi metallo-β-lactamase (NDM)-20 
is a major public health issue.1 Since NDM producers are primarily found among individuals 21 
with history of hospitalization or travel to the India subcontinent, many hospitals have 22 
implemented microbiological screening of patients with such an epidemiological history.1,2  23 
In mid-2011, the stool sample of a one year-old infant was found to have CRE upon 24 
admission screening. The infant was admitted because of cough and intermittent fever in the 25 
preceding two weeks. The family had travelled to and stayed in Hunan province, China in the 26 
preceding month. Following onset of the symptoms, the infant had been admitted to a 27 
hospital in Hunan for 3 days. Patient was given a diagnosis of broncholitis and had been 28 
treated with a course of intravenous cefoperazone. At presentation to our hospital, patient had 29 
fever of 38 oC. Chest examination was unremarkable. Patient was treated conservatively and 30 
the fever resolved without further antibiotic treatment. Patient was discharged 2 days later. In 31 
accordance with the screening policy, stool samples were obtained for surveillance culture.  32 
In brief, a red-bean size faecal pellet was suspended in saline. A 10 L aliquot of the 33 
suspension was then removed and plated directly onto one ChromID ESBL plate. In addition, 34 
a broth enrichment step was performed by inoculating another 10 L aliquot of the faecal 35 
suspension into nutrient broth with 1 mg/L meropenem, incubated at 37 oC overnight, and 36 
then subcultured onto MacConkey plate with 1 mg/L meropenem. All plates were incubated 37 
at 37 oC in air for 20 h. All distinct colony types recovered from either the chromogenic or 38 
the MacConkey media were investigated for evidence of carbapenemase activity using the 39 
combined disc method and boronic acid or EDTA as inhibitor.3 All isolates were identified 40 
using VITEK 2 and antimicrobial susceptibility was determined by the CLSI disc diffusion 41 
method.4  42 
After the patient’s stool samples were found to carry CRE. Stool samples from the 43 
infant’s parents and other family members were also cultured using the same methodology. A 44 
total of four CRE isolates were recovered from the faecal samples of the child and her mother 45 
(Table 1). Cultures of the faecal samples from the other household members (father, 46 
grandfather, grandmother and aunt) were negative. All four isolates (two Escherichia coli, 47 
one Klebsiella pneumoniae and one Enterobacter aerogenes) exhibited synergy with EDTA 48 
in the combined disc testing. No synergy with boronic acid was observed. PCR and 49 
sequencing, using previously described methods confirmed presence of NDM-1 in the four 50 
CRE isolates.2 Additional β-lactamases including other metallo-β-lactamases (IMP, VIM, 51 
GIM, SPM, SIM), CTX-M and OXA-48-like genes were also sought by PCR and 52 
sequencing.5 This allowed identification of an additional extended-spectrum β-lactamase 53 
(ESBL) gene in the K. pneumoniae (CTX-M-65) and the two E. coli (CTX-M-57) isolates. 54 
Next, we studied the relationship between the two E. coli isolates by PFGE after digestion of 55 
their genomic DNAs with XbaI. The two isolates shared the same PFGE banding pattern, 56 
indicating that the two isolates were clonally related. Multilocus sequence typing showed that 57 
the two E. coli strains and the K. pneumoniae strain belonged to ST744 and ST483, 58 
respectively. S1-PFGE demonstrated that the strains had one to three plasmids with sizes of 59 
50-90 kb. Hybridization demonstrated that blaNDM-1 gene was harboured on the 50 kb plasmid 60 
in all the strains. In conjugation experiments,2 the 50 kb blaNDM-1 harbouring plasmid could 61 
be transferred to J53 E. coli recipient at high frequencies (up to 10-1 per donor cell). In the 62 
transconjugants, there was no co-transfer of resistance to the non-β-lactam antibiotics 63 
(amikacin, ciprofloxacin, chloramphenicol, fosfomycin, nalidixic acid, sulphonamides, 64 
tetracycline and trimethoprim). Transconjugants with the blaNDM-1 harbouring plasmid as the 65 
only plasmid was investigated by PCR-based replicon typing and blaCTX-M PCR. The finding 66 
showed that the 50 kb plasmid belonged to an untypeable replicon type and was blaCTX-M 67 
negative.  68 
 Members of this family had no history of travel to the Indian subcontinent. The index 69 
patient is the only one with a history of hospitalization. Therefore, the infant has mostly 70 
likely acquired the blaNDM-1 gene during the hospitalization in Hunan province. This indicates 71 
that some hospitals in mainland China could be reservoirs of the blaNDM-1 gene,6 which may 72 
or may not initially have reached there from the Indian subcontinent. While both the infant 73 
and her mother shared the same E. coli strain, it is impossible to tell if there was intra-familial 74 
transmission as opposed to the mother and the infant both becoming colonized while in 75 
hospital. In China, the burden of CTX-M-producing Enterobacteriaceae is tremendous. 76 
Therefore, accumulation of NDM-1 in multiple CTX-M-producing Enterobacteriaceae 77 
species is worrying.1 In conclusion, this report shows the spread of NDM-1 among persons 78 
with no established links to the Indian subcontinent and demonstrates the usefulness of 79 
admission screening for early identification of NDM-1 for patients who have been treated 80 
aboard. 81 
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Table 1. Characteristics of four carbapenem-resistant Enterobacteriaceae in this study 92 
 Strain (bacterial species) 
 CRE379 
(EA) 
CRE380 
(KP) 
CRE396 
(EC) 
CRE397 (EC)
Specimen source index index index index’s 
mother 
β-lactamase gene contenta NDM-1 NDM-1,  
CTX-M-65 
NDM-1,  
CTX-M-57 
NDM-1,  
CTX-M-57 
Plasmid content (size in 
kb)b  
50 50 50, 90 50, 80, 90 
Inhibition zone diameter  
(mm, with/without EDTA) 
    
Ertapenem 24/9 20/6 16/13 24/6 
Imipenem 23/12 25/15 25/15 27/11 
Meropenem 24/11 24/10 25/13 27/8 
Co-resistance pattern     
Amikacin S S S S 
Chloramphenicol S R R R 
Ciprofloxacin S R R R 
Cotrimoxazole S R R R 
Fosfomycin M S S S 
Gentamicin S R S S 
Nitrofurantoin R R S S 
Tigecyclinec M R S S 
EA, Enterobacter aerogenes; EC, Escherichia coli; KP, Klebsiella pneumoniae 93 
a β-lactamase group-specific PCR was used to assay for presence of NDM, IMP, VIM, KPC, 94 
GES and OXA-48-like genes. 95 
bThe plasmid showed to harbour the blaNDM-1 gene by probe hybridization was underlined. 96 
cThe FDA disc breakpoints was used to interpret tigecycline susceptibility results: sensitive 97 
≥19 mm, intermediate 15-18 mm and resistant ≤14 mm. 98 
99 
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